NeuroSearch reports positive results from ongoing phase Ib clinical study of NsG-0202 in AD April 9, 2008
Transdel receives FDA approval to initiate phase III clinical program for pain drug Ketotransdel April 9, 2008
New treatment option for Alzheimer's disease imparted in recent Merck & Co. and Sunesis patent April 8, 2008
RSS